Status:
COMPLETED
Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal Osteoporosis
Lead Sponsor:
Ufuk University
Conditions:
Osteoporosis, Postmenopausal
Osteoporotic Fractures
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective case-control study. In the study, the data of 304 patients who were evaluated in our clinic between January 2017 and January 2020 with a pre-diagnosis or diagnosis of pos...
Eligibility Criteria
Inclusion
- Having applied to our clinic with the diagnosis or pre-diagnosis of postmenopausal osteoporosis or osteoporosis with pathological fractures
Exclusion
- Having a diagnosis of osteoporosis due to conditions other than postmenopausal osteoporosis
- Those with acute or chronic infection, malignancy and systemic diseases that may change the hematological inflammation parameters to be checked
- Persons who are missing one or more of the parameters planned to be considered among the obtained data
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT04748029
Start Date
January 1 2021
End Date
February 1 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ufuk University
Ankara, Çankaya, Turkey (Türkiye), 06520